Form 4: ACM Research CEO David Wang Sells 90,000 Shares Under 10b5-1 Trading Plan

ACM Research CEO David H. Wang sold 90,000 shares of Class A Common Stock on March 8, 2024, at weighted average prices of $30.36 and $30.35, respectively, under a pre-arranged 10b5-1 trading plan.

Summary

• On March 8, 2024, David H. Wang, CEO, President, and Director of ACM Research, Inc., sold 90,000 shares of Class A Common Stock.
• The sales were executed in two tranches of 45,000 shares each.
• The weighted average price for the first tranche was $30.36, and for the second tranche, it was $30.35.
• The transactions were conducted under a Rule 10b5-1 trading plan adopted on June 13, 2023.
• Following the reported transactions, Wang directly owns 591,107 shares of Class A Common Stock.
• Wang also has indirect ownership through various trusts and family members, including 100,002 shares held by his wife, Jing Chen, 45,837 shares held by his daughter, Sophia Wang, 180,000 shares held by the David Hui Wang and Jing Chen Family Irrevocable Trust for Wang Children, and 620,001 shares held by the Wang-Chen Family Living Trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock sales under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's future.

Industry Context

Insider sales are a common occurrence, but the market often scrutinizes them for signals about a company's prospects. Sales under a 10b5-1 plan are generally viewed as less concerning since they are pre-arranged.

Stakeholder Impact

• Shareholders may react to the news of insider selling, although the existence of a 10b5-1 plan may mitigate concerns.
• The impact on other stakeholders (employees, customers, suppliers, creditors) is likely minimal.

Key Dates